Author: Arundhati Parmar
Source: MedCity News
Interest: Healthcare venture capitalists are no fans of the U.S. Food and Drug Administration and the regulatory challenges the agency poses for medical startups and device companies. They blame many of the problems besetting healthcare investing squarely on the agency as delays caused by reviewers push investor pay day further out.
Link: http://medcitynews.com/2012/05/advice-from-a-vc-to-startups-speak-no-evil-about-the-fda/
Loading...